Clinical Trials: Country-Specific Clinical Trials

Clinical Trial Metrics Benchmarking: China vs US vs EU

October 17, 2025

Sponsors should:
– Benchmark timelines and costs against regional averages during planning.
– Use Tier-1 hospitals in China for faster activation and higher data quality.
– Incorporate training programs for Tier-2 sites to expand recruitment.
– Align trial designs with ICH E17 MRCT guidance for multinational data acceptance.
– Implement bilingual systems to ensure accurate data integration across regions.
– Conduct mock inspections to prepare Chinese sites for FDA, EMA, and NMPA reviews.
These practices improve efficiency and harmonization across regions.

Click to read the full article.

Clinical Trials in China, Country-Specific Clinical Trials

Ethical Challenges in Pediatric Oncology Trials in China

October 18, 2025

digi

Sponsors should:
– Use age-appropriate, illustrated consent and assent materials.
– Involve both parents and children in decision-making while respecting cultural norms.
– Establish specialized pediatric trial sites with trained staff.
– Strengthen ethics committee oversight for pediatric oncology protocols.
– Engage patient advocacy groups for recruitment support.
– Implement pediatric-specific safety monitoring systems.
These measures ensure ethical compliance and patient protection.

Click to read the full article.